Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Crawford, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Crawford, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Annals of Oncology 14:6-7, 2003
© 2003 European Society for Medical Oncology


Editorial

Pegfilgrastim: the promise of pegylation fulfilled

J. Crawford

Division of Medical Oncology and Transplantation, Duke Comprehensive Cancer Center, Duke University Medical Center, Durham, NC, USA

The first 10% of the full text of this article appears below.

The laboratory and clinical investigation of hematopoietic growth factors has had a profound impact on the practice of oncology and the care of cancer patients [1]. In studies with these agents, we have learnt not only about the biological effects these agents have on the hematopoietic system, but also about the clinical benefit that occurs by reducing treatment-related anemia, neutropenia and thrombocytopenia. With regard to the colony-stimulating factors (G-CSF, GM-CSF) our knowledge base continues to grow and guidelines for clinical use continue to undergo revision [2]. In addition to reducing the toxicity of myelosuppressive chemotherapy for millions of cancer patients, these agents have also been integral to the study of chemotherapy dose intensity and dose density. The science of stem cells has been heavily dependent on the study of the hematopoietic cytokines and their regulation and interaction. As a . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?